SCHEDULE 13D/A: Sleep Number Resolves Activist Dispute with Stadium Capital, Announces Board Refreshment

Sleep Number Corporation and activist investor Stadium Capital Management have reached an agreement, terminating a joint filing and solicitation agreement and outlining significant changes to the company's Board of Directors.

Summary

• Stadium Capital Management, LLC, on behalf of its group members, terminated the Joint Filing and Solicitation Agreement (JFSA) with certain individuals, effective March 14, 2025.
• The termination means that Kevin Baker, Gary T. Fazio, Jeffrey T. Jackson, Patrick A. Hopf, and Jessica M. Prager are no longer part of the Section 13(d) group with Stadium Capital.
• Stadium Capital and Sleep Number Corp. entered into a new agreement on March 13, 2025, resolving a potential proxy contest.
• Under the agreement, Stadium Capital irrevocably withdrew its notice to nominate candidates for the 2025 Annual Meeting.
• Three current directors, Michael J. Harrison, Shelly R. Ibach, and Barbara R. Matas, will not stand for re-election at the 2025 Annual Meeting.
• Only Linda Findley, Deborah L. Kilpatrick, and Hilary A. Schneider will be nominated for election to the Board at the 2025 Annual Meeting, with Ms. Schneider reclassified to a term expiring at that meeting.
• Stephen L. Gulis, Jr. will resign from the Board no later than the completion of the Issuer's debt refinancing or the conclusion of the 2026 Annual Meeting, whichever comes first.
• Brenda J. Lauderback will resign from the Board effective December 31, 2025.
• Hilary A. Schneider will be appointed Chair of the Management Development and Compensation Committee of the Board, effective as of the 2025 Annual Meeting.
• Following the 2025 Annual Meeting, the Board will reduce its size to nine directors.
• Upon the earlier of Mr. Gulis's or Ms. Lauderback's resignation, the Board will reduce its size from nine to eight directors.
• Upon the later of Mr. Gulis's or Ms. Lauderback's resignation, the Board will further reduce its size from eight to seven directors.
• Stadium Capital beneficially owns an aggregate of 2,616,459 shares of Sleep Number Common Stock, representing 11.7% of the class.
• Stadium Capital has agreed to vote its shares in favor of Mses. Findley, Kilpatrick, and Schneider at the 2025 Annual Meeting.
• Both Stadium Capital and Sleep Number have agreed not to publicly disparage each other until the agreement's termination date.

Sentiment

Score: 7

Explanation: The sentiment is positive as the document signals the resolution of a potential proxy contest and outlines a clear path for board refreshment and governance changes, which typically reduces uncertainty and can be viewed favorably by investors.

Positives

• Resolution of a potential proxy contest, which typically reduces uncertainty and avoids costly and distracting shareholder disputes.
• Agreement on a clear path for Board refreshment and reduction in size, potentially leading to more efficient governance.
• Stadium Capital's commitment to vote in favor of the agreed-upon director nominees ensures a smooth election process at the 2025 Annual Meeting.

Risks

• The agreement implies prior disagreements or dissatisfaction from Stadium Capital regarding Sleep Number's governance or strategic direction, which could indicate underlying challenges.
• Significant board turnover, while agreed upon, could lead to a temporary period of adjustment or loss of institutional knowledge, though the staggered resignations aim to mitigate this.

Future Outlook

The agreement sets a clear path for significant changes to Sleep Number's Board composition, with a planned reduction in board size from the current structure to nine, then eight, and finally seven directors over time. The agreement is expected to remain in effect until approximately 30 days prior to the 2026 Annual Meeting director nomination deadline or 120 days prior to the first anniversary of the 2025 proxy statement release, ensuring continued stability in governance.

Industry Context

This filing reflects a common scenario in the public markets where activist investors engage with company management to drive changes in corporate governance, strategy, or financial performance. The resolution of a potential proxy fight through a negotiated agreement, including board refreshment and a voting commitment, is a standard outcome in such situations, often aimed at creating shareholder value and avoiding prolonged public disputes.

Management Changes

Corporate Governance

Stakeholder Impact

• Shareholders: The resolution of the activist dispute and the planned board refreshment are likely to be viewed positively, reducing uncertainty and potentially improving corporate governance and long-term value creation.
• Board of Directors: Significant changes in board composition and size will impact the dynamics and decision-making processes within the board.
• Management: The agreement provides clarity and stability by avoiding a contested proxy fight, allowing management to focus on business operations.

Next Steps

• Sleep Number's 2025 Annual Meeting of shareholders will proceed with the agreed-upon director nominations.
• The Board will take actions to reduce its size to nine directors following the 2025 Annual Meeting.
• Stephen L. Gulis, Jr. will resign from the Board upon the earlier of the Issuer's debt refinancing completion or the 2026 Annual Meeting.
• Brenda J. Lauderback will resign from the Board effective December 31, 2025.
• The Board will further reduce its size to eight and then seven directors upon the respective resignations of Mr. Gulis and Ms. Lauderback.

Key Dates

Keywords

Sleep Number Corp, SNBR, Stadium Capital Management, Activist Investor, Corporate Governance, Board of Directors, Proxy Contest, Shareholder Agreement, SEC Filing, Schedule 13D/A, Board Resignation, Board Composition